0 likes | 16 Views
The Glucagon-like peptide-1 (GLP-1) analogs market is estimated to be valued at US$ 11.87 billion in 2023 and is expected to exhibit a CAGR of 1.12% over the forecast period 2023-2028, as highlighted in a new report published by Coherent Market Insights. <br><br><br>Read More... https://www.articleted.com/edit.php?id=671307<br>
E N D